These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Effects of 2-(substituted-sulfanyl)-3,5-dihydro-imidazole-4-one and 2-(substituted-sulfanyl)-1H-imidazole-4,5-dione derivatives on serum HDL-cholesterol. Elokdah H; Sulkowski T; Cochran D; McKean ML; Quinet E Bioorg Med Chem Lett; 2000 Aug; 10(16):1791-4. PubMed ID: 10969969 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents. Bhandari K; Srinivas N; Marrapu VK; Verma A; Srivastava S; Gupta S Bioorg Med Chem Lett; 2010 Jan; 20(1):291-3. PubMed ID: 19913413 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)). Patel CH; Dhanani S; Owen CP; Ahmed S Bioorg Med Chem Lett; 2006 Sep; 16(18):4752-6. PubMed ID: 16870430 [TBL] [Abstract][Full Text] [Related]
19. Novel syntheses of hexahydro-1H-pyrrolo[1,2-a]ĭmidazoles and Octahydroimidazo[1,2-a]pyridines. Katritzky AR; Qiu G; He HY; Yang B J Org Chem; 2000 Jun; 65(12):3683-9. PubMed ID: 10864752 [TBL] [Abstract][Full Text] [Related]